Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop-Reference-Cited by-同舟云学术

Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop

Published:2023-10 Issue:6 Volume:20 Page:1682-1691
ISSN:1878-7479
Container-title:Neurotherapeutics
language:en
Short-container-title:Neurotherapeutics

Author:

Stephenson Diane^ORCID,Belfiore-Oshan Ramona,Karten Yashmin,Keavney Jessi,Kwok D. Kevin,Martinez Terina,Montminy Joe,Müller Martijn L.T.M.,Romero Klaus,Sivakumaran Sudhir

Funder

Center for Drug Evaluation and Research

Publisher

Elsevier BV

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s13311-023-01440-x.pdf

Reference34 articles.

1. Six action steps to address global disparities in Parkinson disease: a World Health Organization priority;Schiess;JAMA Neurol,2022

2. Value of data sharing to advance drug development: a regulatory perspective;Thompson;Ther Innov Regul Sci,2021

3. The role of public–private partnerships in catalyzing the critical path;Maxfield;Clin Transl Sci,2017

4. Public-private partnerships need honest brokering;Goldman;Nat Med,2012

5. Biomarkers in medicines development—from discovery to regulatory qualification and beyond;Hendrikse;Front Med.,2022

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling of Parkinson’s Disease Progression and Implications for Detection of Disease Modification in Treatment Trials;Journal of Parkinson's Disease;2024-09-03

2. A Human Brain-Chip for modelling brain pathologies and screening of BBB crossing therapeutic strategies;2024-08-12

3. Parkinson's disease: Still waiting for a cure;Clinical and Translational Science;2024-07

4. An Investigation of Parameter-Dependent Cell-Type Specific Effects of Transcranial Focused Ultrasound Stimulation Using an Awake Head-Fixed Rodent Model;2024-06-28

5. Artificial Intelligence and Disease Modeling: Focus on Neurological Disorders;Clinical Pharmacology & Therapeutics;2024-03-13